Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · IEX Real-Time Price · USD
1.880
-0.070 (-3.59%)
At close: May 21, 2024, 2:13 PM
1.870
-0.010 (-0.53%)
After-hours: May 21, 2024, 6:32 PM EDT

Applied DNA Sciences Income Statement

Millions USD. Fiscal year is Oct - Sep.
Year 20232022202120202019 2018 - 2007
Revenue
13.3718.179.031.935.39
Upgrade
Revenue Growth (YoY)
-26.43%101.25%367.40%-64.16%38.06%
Upgrade
Cost of Revenue
7.8313.124.540.830.88
Upgrade
Gross Profit
5.535.054.481.14.51
Upgrade
Selling, General & Admin
12.7515.112.8510.0310.28
Upgrade
Research & Development
3.743.934.163.322.97
Upgrade
Other Operating Expenses
000.820.290.39
Upgrade
Operating Expenses
16.4919.0217.8313.6413.64
Upgrade
Operating Income
-10.95-13.97-13.35-12.53-9.12
Upgrade
Interest Expense / Income
00-0.010.120.16
Upgrade
Other Expense / Income
-1.01-5.70.950.38-0.68
Upgrade
Pretax Income
-9.95-8.27-14.29-13.03-8.61
Upgrade
Income Tax
00000.02
Upgrade
Net Income
-9.95-8.27-14.29-13.03-8.62
Upgrade
Preferred Dividends
00.11000.31
Upgrade
Net Income Common
-9.95-8.38-14.29-13.03-8.93
Upgrade
Shares Outstanding (Basic)
10000
Upgrade
Shares Outstanding (Diluted)
10000
Upgrade
Shares Change
45.81%29.65%76.50%325.16%25.00%
Upgrade
EPS (Basic)
-15.20-18.60-41.40-66.40-193.80
Upgrade
EPS (Diluted)
-15.20-18.60-41.40-66.40-193.80
Upgrade
Free Cash Flow
-6.25-9.47-15.94-12.21-6.93
Upgrade
Free Cash Flow Per Share
-9.56-21.11-46.08-62.29-150.34
Upgrade
Gross Margin
41.39%27.82%49.66%57.14%83.72%
Upgrade
Operating Margin
-81.94%-76.89%-147.86%-648.98%-169.31%
Upgrade
Profit Margin
-74.41%-46.11%-158.25%-674.61%-165.76%
Upgrade
Free Cash Flow Margin
-46.76%-52.10%-176.53%-631.98%-128.58%
Upgrade
EBITDA
-8.58-6.98-13.46-12.63-8.06
Upgrade
EBITDA Margin
-64.22%-38.40%-149.05%-653.67%-149.47%
Upgrade
Depreciation & Amortization
1.361.290.840.290.39
Upgrade
EBIT
-9.95-8.27-14.3-12.91-8.45
Upgrade
EBIT Margin
-74.41%-45.51%-158.40%-668.47%-156.72%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).